Because of the global obesity epidemic, the incidence and prevalence of nonalcoholic fatty
liver disease (NAFLD) have increased worldwide, including among Koreans. Recently, the …

Type 2 diabetes mellitus is often associated with cirrhosis as comorbidities, acute illness,
medications, and other conditions profoundly alter glucose metabolism. Both conditions are …

Non-alcoholic fatty liver disease (NAFLD) is a major cause of liver disease worldwide,
affecting up to 30% of adults. Progression to non-alcoholic steatohepatitis (NASH) is a key …

Nonalcoholic fatty liver disease (NAFLD) is the most common liver disease, with a global
prevalence estimated at approximately 25%. NAFLD is also the leading cause of liver …

Background & Aims Nonalcoholic fatty liver disease (NAFLD) and sarcopenia can be
associated with advanced liver disease. Our aim was to assess the association between …

Background. Few studies have specifically observed the relationship of sarcopenia, visceral
obesity, or their joint effects with lean NAFLD in patients with diabetes. We aimed to …

Sarcopenia is defined as a progressive loss of skeletal muscle mass, strength, and function.
1 Sarcopenia is often associated with ageing and frailty and, more recently, has been linked …

Backgrounds The association between obesity and asthma has been of interest, but whether
the duration of asthma has an effect on obesity is still limitedly studied. Aim The purpose of …

Rationale and Objectives To define sarcopenic obesity (SaO) among chronic liver disease
(CLD) patients via CT and MRI, and assess its impact on liver disease severity. Materials …

Background: The annual incidence of non-alcoholic fatty liver disease (NAFLD) continues to
rise steadily. In recent years, adipose tissue (AT) has gained recognition as a pivotal …